NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression

Clinical trial NCT03396601 · UNKNOWN

Trial details

NCT number: NCT03396601
Sponsor: NeuroRx, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Depression Suicidal Ideation

Start date: 2019-06-25
Primary completion: 2024-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.